Percutaneous AV Fistula Creation Success

It has been three years now since the introduction of the WavelinQ EndoAVF procedure. Performed as an outpatient procedure under conscious sedation, it takes approximately an hour. The FDA and European trials showed high technical success rates for fistula creation and fistula utilization. The average time from creation to the time of being able to be used is about 50 days, much shorter than traditional surgically created fistulas.

Additionally, the functional patency of the percutaneous fistula was higher compared to surgical fistulas, required fewer interventions to keep them functional and did not result in the typical cosmetic deformities that can occur with surgically created fistulas (like venous pseudoaneurysms). Banner McKee Medical Center was the first hospital in Colorado to offer this procedure to patients who are nearing end-stage renal disease. According to Dr. Richard Coursey, Jr., vascular/interventional radiologist at RIA Endovascular, “This new procedure requires no incision, no general anesthesia and is performed in about an hour as an outpatient.

“We know it is hard for patients to come to terms with the fact that they are going to need to go on dialysis. The WavelinQ procedure allows me the ability to help patients transition to dialysis care more quickly, with less patient stress, and hopefully will also decrease the amount of days patients will require catheter-based dialysis.”

To find out more about this procedure, contact us.

Find more information here: riaendovascular.com/2020/07/28/dr-richard-coursey-jr-performs-first-procedure-of-its-kind-in-colorado